Harris, LE, Morgan, DGA and Balthasar, N (2014) Growth hormone secretagogue receptor deficiency in mice protects against obesity‐induced hypertension. Physiological Reports, 2 (3). e00240-?. ISSN 2051-817X

[thumbnail of e00240.full.pdf]
e00240.full.pdf - Accepted Version
Available under License Creative Commons Attribution.

Download (419kB) | Preview


Growth hormone secretagogue receptor (GHS‐R) signaling has been associated with growth hormone release, increases in food intake and pleiotropic cardiovascular effects. Recent data demonstrated that acute GHS‐R antagonism leads to increases in mean arterial pressure mediated by the sympathetic nervous system in rats; a highly undesirable effect if GHS‐R antagonism was to be used as a therapeutic approach to reducing food intake in an already obese, hypertensive patient population. However, our data in conscious, freely moving GHS‐R deficient mice demonstrate that chronic absence of GHS‐R signaling is protective against obesity‐induced hypertension. GHS‐R deficiency leads to reduced systolic blood pressure variability (SBPV); in response to acute high‐fat diet (HFD)‐feeding, increases in the sympathetic control of SBPV are suppressed in GHS‐R KO mice. Our data further suggest that GHS‐R signaling dampens the immediate HFD‐mediated increase in spontaneous baroreflex sensitivity. In diet‐induced obesity, absence of GHS‐R signaling leads to reductions in obesity‐mediated hypertension and tachycardia. Collectively, our findings thus suggest that chronic blockade of GHS‐R signaling may not result in adverse cardiovascular effects in obesity.

Item Type: Article
Uncontrolled Keywords: diet-induced obesity, ghrelin, growth hormone secretagogue receptor, hypertension
Subjects: Q Science > QR Microbiology
Divisions: Faculty of Natural Sciences > School of Life Sciences
Depositing User: Symplectic
Date Deposited: 19 May 2015 14:44
Last Modified: 20 May 2019 11:27
URI: https://eprints.keele.ac.uk/id/eprint/534

Actions (login required)

View Item
View Item